COL3A1 and esophageal cancer: Together, these mechanisms suggest that COL3A1, PLAU, and SPP1 not only serve as promising biomarkers for early-stage esophageal cancer but also contribute to the pathophysiology of the disease by facilitating key processes such as migration, invasion, and proliferation.